III. Abstracts
1. Haring Ch., Barnas Ch., Fleischhacker W. W., Mil er C., Unterweger B. (1986) Suicide among elderly people.
Neurologija,Suppl. 35:135 2.Barnas Ch., Stuppäck Ch., Unterweger B., Haring Ch., Fleischhacker W. W., Hinterhuber H. (1988)
Zotepine vs. Haloperidol in acute schizophrenia: Results of a double blind trial. Psychopharmacol. Suppl 96:205 3.Humpel Ch., Haring Ch., Auer B., Saria A., Barnas Ch.,
Fleischhacker W. W., Hinterhuber H. (1988) Clozapine Plasma Levels determined by HPLC and UV Detection. Psychopharmacol. Suppl 96:345
4. Haring Ch., Barnas Ch., Humpel Ch., Saria A., Fleischhacker W.W., Hinterhuber H. (1988) Dose related Plasma Levels of Clozapine: Differences in Smokers and Non- Smokers. Psychopharmacol. Suppl 96:186
5.Haring Ch., Humpel Ch., Saria A. (1988) Release of multiple Tachykinins and Calcitonin Gene-Related Peptide for Rat Brain Slices in Vitro. Biol. Chemistry, HS. 369: 831
Haring Ch., Barnas Ch., Humpel Ch., Saria A., Fleischhacker W.W., Hinterhuber H. (1988) Dosis Plasmaspiegel Korrelation bei Clozapin: Einfluß von Rauchen und Geschlecht. Fortschritte der Neurologie Psychiatrie 56:20
7. Saria A., Humpel Ch., Haring Ch., Marksteiner J., Sperk G. (1989) Modulation of Synthesis and Release of Multiple Tachykinins in the Rat Brain by Pharmacological and Neurotoxical Approaches.
J. Neurochemistry (Suppl.) 8. Haring Ch., Humpel Ch., Saria A. (1989) Calcitonin gene-related peptide in the amygdaloid complex of the rat: Tissue distribution and
pharmacological modulation of the potassium evoked release. J. Neurochemistry (Suppl.)
9.Barnas Ch., Haring Ch., Saria A., Humpel Ch., Fleischkacker W.W. (1989)
Influence of patient-related variables on plasma levels of clozapine. Schiz. Res. 2; 193 10.Haring Ch., Barnas Ch., Humpel Ch., Saria A.,Fleischhacker W.W. (1989)
Influence of sex, age and smoking behaviour on the pharmacokinetics of clozapine: Evaluation of plasma-level curves using repeated measurements after a single oral dose. Schiz. Res. 2; Abstract addendum 5
11. Haring Ch., Humpel Ch., Saria A. (1989) Calcitonin Gene-related Peptide like Immunoreactivity in the Amygdaloid complex of the Rat:Immunohistochemical and Quantitative distribution and Drug Effects on Calcium Dependent, Potassium evoked in Vitro Release.
Pharmacopsychiatry 22; 199 12. Haring Ch., Javorsky F., Humpel Ch., Saria A. Modulation of the release of substance P- and neurockinin A-like peptides from the rat amygdaloid complex,
hippocampus, substantia nigra and striatum. Eurp. J Neuroscience, 1989 13.Mil er C., Barnas Ch., Stuppäck Ch., Ehrmann H., Haring Ch.
Studien zur Therapieführung mit Antidepressiva der neuen Generation. Öster.Ärztezt. 1989, 17a; 92 14.Barnas Ch., Haring Ch., Meise U., Mil er C., Stuppäck Ch.
Informationspflicht bei der Verschreibung von Benzodiazepinen. Öster.Ärztezt. 17a; 95 15. Haring Ch., Mil er C.H., Barnas Ch., Humpel Ch., Saria A.,
Neudorfer C., Fleischhacker W.W. Kinetics of oral clozapine Schizophrenia Res. 1990, 3; 42
16.Saria A., Haring Ch., Humpel Ch., Skofitsch G., Krobath J. (1990) Calcitonin gene-related peptide in the amygdaloid complex of the rat: Immunhistochemical and quantitativ distribution and drug effects on the calcium dependent, potassium evoked in vitro release.
Schizophrenia Res. 3; 42 17.Barnas Ch., Fleischhacker W.W., Stuppäck ch., Mil er C., Haring Ch., Unterweger B., Hinterhuber H. (1990)
Zotepine versus haloperidol in the treatment of schizophrenia with prevailingly negative symptoms. Psychopharmacol. Suppl 18.Haring Ch., Schett P., Saria A., Fleischhacker W.W. (1990)
Plasma levels of clozapine: influence of age, sex, weight, dose and smoking behaviour.
Arensman E., Kerkhof A., Dirkzwager A., Verduin Z.J., Bille-Brahe U., Bjerke T., Crepet P., De Leo D., Haring Ch., Hawton K., Lunnqvist J., Michel K., Querejeta I., Salander-Renberg E., Schmidtke A.,
Temesvary B., Wasserman D. (1998) Prevalence and risk factors for repeated suicidal behaviour: Results from the WHO/EURO study on Parasuicide 1989 – 1992 7th European Symposium on Suicide and Suicidal Behaviour, 09-12.9.1998 in Gent, Belgium
Maani, Dunkel D., Lehofer M., Haring Ch., Antretter E., Fitzeck T. (1998). Schizophrenia and Suizide. 7th European Symposium on Suicide and Suicidal Behaviour, 09-12.9.1998 in Gent, Belgium
21. Jessen G., Jessen B.F., Arensman E., Bille-Brah U., Crepet P., De Leo D., Hawton K., Haring Ch., Hjelmeland H., Michel K., Ostamo A., Salander-Renberg E., Schmidtke A., Temesvary B., Wassermann D. (1998). Transposition of suicidal behaviour: Suicide attempts around public holidays in Europe.
7th European Symposium on Suicide and Suicidal Behaviour, 09-12.9.1998 in Gent, Belgium 22. Haring Ch. (2000). Comorbidität bei affektiven Störungen. Psychiatria Danubia 1(12) p 86
Human Reproduction, Vol.24, No.12 pp. 3196 – 3204, 2009Advanced Access publication on October 3, 2009ORIGINAL ARTICLE Reproductive epidemiologyPhysical activity and fertility in women:the North-Trøndelag Health StudyS.L. Gudmundsdottir1, W.D. Flanders2, and L.B. Augestad1,31Human Movement Science Programme, Faculty of Social Sciences and Technology Management, Norwegian University of Sci
From the Haemostasis, Thrombosis & Vascular Biology Unit, University Department ofMedicine, City Hospital, Birmingham, UK The term ‘microalbuminuria’ has been introducedthelial damage or dysfunction, such as vonto describe a measurable increase in urine albuminWillebrand factor, suggests the possibility thatexcretion, which is still within normal total urinemicroalbuminuria may be a